Literature DB >> 9684463

Improved device for measuring scratching activity in patients with pruritus.

H A Molenaar1, J Oosting, E A Jones.   

Abstract

Pruritus is an inherently subjective perception that cannot be quantified. However, in trials of new therapies for pruritus, it is necessary to base assessments of therapeutic efficacy on objective quantitative criteria. This can be achieved by measuring the behavioural consequence of pruritus, scratching activity, and using an index of scratching activity as an efficacy endpoint. A portable device to monitor scratching activity in patients with pruritus is described. The key feature of this device is a piezo-element attached to a fingernail. Vibrations of the fingernail in the act of scratching induce electrical impulses in the piezo-element. Electrical signals from the device are filtered and measured. The measurements, which are not absolute, have nevertheless been shown to provide an objective index of scratching activity that is independent of arm and hand movements. An advantage of the device is that recordings can be made while the patient is in a normal, non-hospital environment, thereby obviating effects of change of environment (e.g. hospitalisation) on the intensity of pruritus. Application of the device enables data on scratching activity during periods of treatment with a test drug and with a placebo to be compared in individual patients.

Entities:  

Mesh:

Year:  1998        PMID: 9684463     DOI: 10.1007/bf02510746

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  8 in total

1.  A new method for the measurement of itch and the response to treatment.

Authors:  R Felix; S Shuster
Journal:  Br J Dermatol       Date:  1975-09       Impact factor: 9.302

2.  Application of piezo film technology for the quantitative assessment of pruritus.

Authors:  T L Talbot; J M Schmitt; N V Bergasa; E A Jones; E C Walker
Journal:  Biomed Instrum Technol       Date:  1991 Sep-Oct

3.  Rapid eye movement cycle is a sleep-dependent rhythm.

Authors:  J Moses; A Lubin; L C Johnson; P Naitoh
Journal:  Nature       Date:  1977-01-27       Impact factor: 49.962

4.  Ultradian rhythms in extended performance.

Authors:  W C Orr; H J Hoffman; F W Hegge
Journal:  Aerosp Med       Date:  1974-09

Review 5.  The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids.

Authors:  N V Bergasa; E A Jones
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

6.  Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.

Authors:  N V Bergasa; D W Alling; T L Talbot; M G Swain; C Yurdaydin; M L Turner; J M Schmitt; E C Walker; E A Jones
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

7.  A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.

Authors:  N V Bergasa; T L Talbot; D W Alling; J M Schmitt; E C Walker; B L Baker; J C Korenman; Y Park; J H Hoofnagle; E A Jones
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

8.  The measurement of itch with sensitive limb movement meters.

Authors:  J A Summerfield; M E Welch
Journal:  Br J Dermatol       Date:  1980-09       Impact factor: 9.302

  8 in total
  3 in total

Review 1.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 2.  Fatigue complicating chronic liver disease.

Authors:  E Anthony Jones
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  Pruritus in chronic liver disease: mechanisms and treatment.

Authors:  Nora V Bergasa
Journal:  Curr Gastroenterol Rep       Date:  2004-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.